Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
Additionally, for medical products in these categories subject to premarket approval, FDA will suspend review of any pending regulatory submissions unless the submission is: an emergency IND; or an IND amendment related to the safety of human subjects (e.g. an IND safety report)
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.